Neurogene Inc. (NGNE)
NASDAQ: NGNE
· Real-Time Price · USD
34.37
1.17 (3.52%)
At close: Oct 15, 2025, 3:59 PM
34.40
0.09%
After-hours: Oct 15, 2025, 06:00 PM EDT
Neurogene Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 925K | n/a | n/a | n/a |
Cost of Revenue | 3.25M | 3.26M | 3.2M | 2.28M |
Gross Profit | -2.32M | -3.26M | -3.2M | -2.28M |
Operating Income | -82.61M | -55.58M | -56.52M | -50.53M |
Interest Income | 8.47M | 2.95M | 1.34M | 19K |
Pretax Income | -75.14M | -36.32M | -55.19M | -50.52M |
Net Income | -75.14M | -36.32M | -55.19M | -50.52M |
Selling & General & Admin | 22.61M | 11.19M | 9.01M | 8.27M |
Research & Development | 60.92M | 44.39M | 47.51M | 42.26M |
Other Expenses | -3.25M | -3.26M | -3.2M | -42.26M |
Operating Expenses | 80.28M | 52.32M | 53.32M | 8.27M |
Interest Expense | 12K | 12K | 2K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 83.53M | 55.58M | 56.52M | 50.53M |
Income Tax Expense | n/a | n/a | -5K | n/a |
Shares Outstanding (Basic) | 17.57M | 12.82M | 12.82M | 55.04M |
Shares Outstanding (Diluted) | 17.57M | 12.82M | 12.82M | 55.04M |
EPS (Basic) | -4.28 | -2.83 | -4.3 | -0.92 |
EPS (Diluted) | -4.28 | -2.83 | -4.3 | -0.92 |
EBITDA | -71.89M | -52.29M | -51.99M | -49.59M |
EBIT | -75.13M | -55.58M | -55.19M | -50.53M |
Depreciation & Amortization | 3.25M | 3.3M | 3.2M | 947K |
Source: Financial Modeling Prep. Financial Sources.